NCT00004113View on ClinicalTrials.gov

Temozolomide in Treating Patients With Recurrent Malignant Glioma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1999

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

temozolomide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER